What happened
Aramco-backed Prosperity7 Ventures led an investment bringing Insilico Medicine's Series D to US$95M (10 Aug 2022); Insilico uses generative AI for drug discovery.
← Back to Deployment Intelligence
InvestmentHealthcare AIM&A / Investment2022SA-12
Insilico Medicine · Saudi Arabia
Middle East·Group: Insilico Medicine
Source: Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures (2022)Medium
How to read these numbers: A purposive, publicly sourced case library, not a probability sample: counts describe the library, not market share. Monetary figures mix investment, revenue and user metrics — treat them as magnitude markers and defer to the verbatim description and source link.
Structured fields
- Host country
- Saudi Arabia
- Region
- Middle East
- AI segment
- Healthcare AI
- Entry mode
- M&A / Investment
- Entry year
- 2022
- Deployment status
- Investment
- Capital direction
- Gulf->China (inbound investment)
- Company group
- Insilico Medicine
Local partner
Prosperity7 Ventures
Sovereign fundState-linked partner
Scale
US$95M Series D total (P7-led add-on)
Basis: company-disclosedMagnitude marker: ~95,000,000 USD
Monetary fields mix investment, revenue and user metrics. Treat them as magnitude markers only — never sum them across records; defer to the verbatim wording and source above.
Sources & notes
Source: Insilico Medicine Announces New Investment Led by Aramco-backed Prosperity7 Ventures (2022)Medium
Record note: Nationality ambiguous (HK/US HQ, major China R&D) — 'verifiably Chinese-backed' is borderline; PI may down-weight.
Compiled from public reporting and company disclosures. Not legal or investment advice — cite the source link alongside any quotation.
Related records
Other records in the same host country or AI segment, ranked by source reliability and year.
United Imaging Healthcare
Saudi Arabia·Middle East
Announced-concreteSA-18
Healthcare AIJoint Venture / Strategic Partnership2025
At Arab Health 2025 (Feb 2025) United Imaging announced a multi-disciplinary collaboration with Saudi Arabia's Al Mana Group spanning CT, radiotherapy, molecular imaging and AI, delivered via its uAI platform (AI-assisted reconstruction/diagnosis).